PhosLo: profile and news

Nabi Biopharmaceuticals Announces First Quarter 2006 Financial ...  Apr 26, 2006
...- Gains in Product Revenues and Margins Led by PhosLo - - Significant Progress Made in Advancing Key Strategic Objectives - BOCA RATON, Fla., April 26 ... - PR Newswire (press release),

Nabi Biopharmaceuticals Announces First Quarter 2006 Financial ...  Apr 26, 2006
...announced gains in total revenues and the gross margin earned on sales in the first quarter of 2006 primarily reflecting strong results for PhosLo(R) (calcium ... - PR Newswire (press release),

Genzyme says petition against Renagel ‘inaccurate’  May 12, 2006
...was not available for immediate contact. Nabi sells PhosLo, a rival drug to Genzyme’s Renagel. According to the petition, Nolan ... - Renal Business Today,

New anti-smoking drug may rival Nabi vaccine  May 11, 2006
Nolan noted that he has done consulting work for Boca Raton-based Nabi, which sells PhosLo, Renagel's biggest competitor. If the ... - Palm Beach Post,

Nabi strikes plasma deal as losses rise  Apr 26, 2006
McLain pointed to a jump in the sale of PhosLo, a medication that reduces dangerously high phosphate levels in the blood, as evidence that the drug is on track ... - Palm Beach Post,

Doctor calls for withdrawal of Renagel  May 11, 2006
In the petition, Nolan used data provided by Nabi Pharmaceuticals, which sells the rival drug PhosLo. Nolan has consulted with Nabi in the past. ... - Renal Business Today,

Nabi Biopharmaceuticals Announces Results of 2006 Annual Meeting ...  May 12, 2006
The company has three products on the market today: PhosLo® (calcium acetate), Nabi-HB® [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol ... - Yahoo! News (press release)

Nabi logs larger loss in Q1  Apr 27, 2006
...longer sells. The company credited much of its most recent revenue gain to PhosLo, a drug for patients with kidney disease. Nabi ... - Bizjournals.com,